Literature DB >> 7962725

Effect of mixed live vaccine (Newcastle disease and infectious bronchitis) and Mycoplasma gallisepticum on the chicken respiratory tract and on Escherichia coli infection.

K Nakamura1, H Ueda, T Tanimura, K Noguchi.   

Abstract

Interaction between mixed live vaccine (Newcastle disease and infectious bronchitis), Mycoplasma gallisepticum (MG) and Escherichia coli (EC) was studied in specific-pathogen-free chickens, aged 7 days, inoculated intranasally. In the tracheas of chickens inoculated with vaccine, MG and EC, profuse multiplication of EC occurred together with severe and persisent histological lesions, and some birds died from EC infection. Similar though less dramatic effects occurred in birds that received vaccine and EC. The tracheas of chickens inoculated with the vaccine alone, or with MG and EC, or with MG alone, showed comparatively mild effects. There were no histological lesions in the tracheas of chickens inoculated with EC alone. This study suggests that the field use of mixed live vaccine in flocks infected with MG may induce EC septicaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962725     DOI: 10.1016/s0021-9975(05)80109-4

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  3 in total

1.  Disinfection by hydrogen peroxide nebulization increases susceptibility to avian pathogenic Escherichia coli.

Authors:  Leon H Oosterik; Huruma N Tuntufye; Steven Janssens; Patrick Butaye; Bruno M Goddeeris
Journal:  BMC Res Notes       Date:  2015-08-27

2.  Infectious bronchitis virus: Immunopathogenesis of infection in the chicken.

Authors:  G D Raj; R C Jones
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

3.  The role of phagocytic cells in enhanced susceptibility of broilers to colibacillosis after Infectious Bronchitis Virus infection.

Authors:  Mark P Ariaans; Mieke G R Matthijs; Daphne van Haarlem; Peter van de Haar; Jo H H van Eck; Evert J Hensen; Lonneke Vervelde
Journal:  Vet Immunol Immunopathol       Date:  2008-02-16       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.